Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus in Active Rheumatoid Arthritis (TREASURE)
NCT01511003Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2011
- Primary completion
- May 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus + Wuzhi capsule in rheumatoid arthritis (RA), sponsored by Astellas Pharma. Primary endpoint: ACR20 response rate at 6 months. Started Dec 2011; status: completed.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01511003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01511003.